- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06780150
En studie för att undersöka effekterna av Ocrelizumab-behandling på NfL-nivåer och deltagarnas tillfredsställelse hos deltagare med multipel skleros (MS) (SurfSubQ)
En prospektiv longitudinell multicenterobservationsstudie för att undersöka nivåer av neurofilament lätta kedjor och patienttillfredsställelse efter subkutan administrering av Ocrelizumab hos personer med multipel skleros
The main purpose of the study is to evaluate participant satisfaction after administration of ocrelizumab subcutaneously (SC) after 12 months using the therapy administration satisfaction questionnaire subcutaneous (TASQ-SC).
Studieöversikt
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Reference Study ID Number: ML45551 https://forpatients.roche.com/ No attachments to email below
- Telefonnummer: 888-662-6728 (U.S. Only)
- E-post: global-roche-genentech-trials@gene.com
Studera Kontakt Backup
- Namn: Fastest response: use the inquiry form https://www.gene.com/contact-us/submit-medical-inquiry
Studieorter
-
-
-
Bern, Schweiz, 3010
- Rekrytering
- Inselspital-Universitaetsspital Bern
-
Zurich, Schweiz, 8001
- Rekrytering
- Bellevue Medical Grop AG
-
-
-
-
-
Aachen, Tyskland, 52074
- Rekrytering
- Uniklinik RWTH Aachen
-
Amberg, Tyskland, 92224
- Rekrytering
- Gesundheitszentrum St. Marien GmbH
-
Arnsdorf, Tyskland, 01477
- Rekrytering
- Sächsisches Krankenhaus Arnsdorf
-
Aschaffenburg, Tyskland, 63739
- Rekrytering
- Neuropraxis im Stadtpalais Dres. Ulzheimer/Herröder/Wessig GbR
-
Bad Soden, Tyskland, 65812
- Rekrytering
- Neurologie Bad Soden
-
Bamberg, Tyskland, 96052
- Rekrytering
- Neurologische Praxis - Kallmann Neurologie - mszb
-
Berg, Tyskland, 82335
- Indragen
- Marianne-Strauß-klinik
-
Berlin, Tyskland, 13347
- Rekrytering
- Jüdisches Krankenhaus Berlin
-
Berlin, Tyskland, 12099
- Rekrytering
- NEUROZENTRUM tempelhof.berlin
-
Berlin, Tyskland, 10713
- Rekrytering
- Neurologisches Facharztzentrum Berlin am Sankt Gertrauden-Krankenhaus
-
Berlin, Tyskland, 12099
- Rekrytering
- Praxis Dr. Said Masri
-
Berlin, Tyskland, 14169
- Rekrytering
- NeuroZentrum Zehlendorf Dr. Ringel und Dr. Scherer
-
Berlin, Tyskland, 14195
- Rekrytering
- Neurologisches Zentrum für Bewegungsstörungen und Diagnostik
-
Bochum, Tyskland, 44791
- Rekrytering
- St. Josef-Hospital
-
Bogen, Tyskland, 94327
- Rekrytering
- Dres. Lippert/Kausch
-
Buchholz, Tyskland, 21244
- Indragen
- Krankenhaus Buchholz Abt. Neurologie
-
Celle, Tyskland, 29223
- Rekrytering
- Neuropraxis Celle: Praxis für Neurologie & Psychatrie
-
Celle, Tyskland, 29223
- Rekrytering
- Allgemeines Krankenhaus Celle / Klinik für Neurologie
-
Chemnitz, Tyskland, 09117
- Aktiv, inte rekryterande
- Praxisgemeinschaft Dres. Sylke Domke und Vasil Gjaurov
-
Cologne, Tyskland, 50935
- Rekrytering
- NeuroMed Campus Neurologische Gemeinschaftspraxis am St. Elisabeth Krankenhaus
-
Dortmund, Tyskland, 44137
- Indragen
- Gemeinschaftspraxis Dr. med. Josef Leclaire und Dr. med. Thomas Rotermund
-
Düsseldorf, Tyskland, 40225
- Rekrytering
- Universitätsklinikum Düsseldorf
-
Düsseldorf, Tyskland, 40211
- Rekrytering
- Gemeinschaftspraxis für Neurologie
-
Düsseldorf, Tyskland, 40625
- Indragen
- Nervenarztpraxis Gerresheim
-
Eltville, Tyskland, 65343
- Rekrytering
- Gemeinschaftspraxis für Neurologie und Psychiatrie, Psychotherapie
-
Erbach/Odenwald, Tyskland, 64711
- Rekrytering
- NeuroCentrum Odenwald
-
Erlangen, Tyskland, 91054
- Rekrytering
- Universitätsklinikum Erlangen, Neurologische Klinik
-
Essen, Tyskland, 45138
- Rekrytering
- Zentrum für ambulante Neurologie / Praxis Knorn Landefeld Friedrich
-
Essen, Tyskland, 45257
- Rekrytering
- Praxis Nervenstark
-
Forchheim, Tyskland, 91301
- Avslutad
- Praxis für Neurologie, Nervenheilkunde & Neurochirurgie
-
Frankfurt, Tyskland, 65929
- Rekrytering
- Varisano Klinikum Frankfurt Höchst GmbH
-
Frankfurt, Tyskland, 60528
- Rekrytering
- Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
-
Freiburg im Breisgau, Tyskland, 79106
- Rekrytering
- Universitätsklinikum Freiburg, Klinik für Neurologie und Neurophysiologie
-
Füssen, Tyskland, 87629
- Rekrytering
- Praxis im Bahnhof
-
Giessen, Tyskland, 35392
- Rekrytering
- Universitätsklinikum Gießen und Marburg GmbH
-
Gladenbach, Tyskland, 35075
- Rekrytering
- Neurologie & Psychiatrie Gladenbach - MS-Zentrum
-
Günzburg, Tyskland, 89312
- Rekrytering
- MVZ Bezirkskliniken Schwaben, Standort Günzburg
-
Halle, Tyskland, 06120
- Rekrytering
- Krankenhaus Martha-Maria Halle-Doelau
-
Hamburg, Tyskland, 20249
- Rekrytering
- Neurologische Praxis Eppendorf
-
Hamburg, Tyskland, 20246
- Rekrytering
- Universiätsklinikum Hamburg-Eppendorf
-
Hanover, Tyskland, 30171
- Rekrytering
- Neurologische Praxis
-
Hennigsdorf, Tyskland, 16761
- Rekrytering
- Oberhavel Kliniken GmbH, Klinik Hennigsdorf, Neurologie
-
Herford, Tyskland, 32052
- Rekrytering
- Praxis Dr. Hospely
-
Hettingen, Tyskland, 72513
- Rekrytering
- Haus- und Facharztzentrum Laucherttal / Alb
-
Ibbenbueren, Tyskland, 49477
- Rekrytering
- Klinikum Ibbenbüren gmbH
-
Isselburg, Tyskland, 46419
- Rekrytering
- Augustahospital Anholt;Neurologie
-
Jena, Tyskland, 07747
- Rekrytering
- Universitätsklinikum Jena, Klinik für Neurologie
-
Kiel, Tyskland, 24105
- Rekrytering
- Uniklinik Schleswig-Holstein
-
Leipzig, Tyskland, 04315
- Rekrytering
- Neurologische Praxis Dr. Ehrlich
-
Leipzig, Tyskland, 04299
- Rekrytering
- Arztpraxis Dr. med. Torsten Sühnel
-
Lübeck, Tyskland, 23538
- Rekrytering
- Universitätsklinik Schleswig Holstein, Campus Lübeck
-
Magdeburg, Tyskland, 39120
- Rekrytering
- Universitätsklinikum Magdeburg
-
Magdeburg, Tyskland, 39104
- Rekrytering
- Neurologie im Ulrichshaus Magdeburg
-
Mannheim, Tyskland, 68167
- Rekrytering
- Universitätsklinikum Mannheim
-
Mannheim, Tyskland, 68163
- Rekrytering
- Neuroplus Dres. Lennart Thilmann/ Patrick Thilmann
-
Marburg, Tyskland, 35043
- Rekrytering
- Universitätsklinikum Giessen und Marburg
-
Meerbusch, Tyskland, 40667
- Rekrytering
- Praxis Dr. Leussink
-
Minden, Tyskland, 32423
- Rekrytering
- Neurologie am Preußenmuseum
-
München, Tyskland, 81675
- Rekrytering
- Praxis für Neurologie und Psychiatrie am Prinzregentenplatz
-
München, Tyskland, 80939
- Rekrytering
- Neurologie München Nord
-
München, Tyskland, 81675
- Rekrytering
- Klinikum rechts der Isar der TU München
-
Münster, Tyskland, 48149
- Rekrytering
- Universitätsklinikum Münster
-
Münster, Tyskland, 48165
- Rekrytering
- Herz-Jesu-Krankenhaus Hiltrup GmbH
-
Neu-Ulm, Tyskland, 89231
- Rekrytering
- Neurologisch-psychiatrische Praxis im A4
-
Neuburg am Inn, Tyskland, 86633
- Rekrytering
- Praxis Dr. med. Bergmann
-
Neuruppin, Tyskland, 16816
- Rekrytering
- Ruppiner Kliniken, Hochschulklinikum der Medizinischen Hochschule Brandenburg, Klinik für Neurologie
-
Nuremberg, Tyskland, 90451
- Rekrytering
- Neurologie Nürnberg-Eibach
-
Nuremberg, Tyskland, 90419
- Rekrytering
- Gemeinschaftspraxis Uhlig und Windsheimer
-
Osnabrück, Tyskland, 49074
- Indragen
- Neurologie an der Hase
-
Pforzheim, Tyskland, 75172
- Rekrytering
- Facharztpraxis für Neurologie und Psychiatrie Dres Mattes/Stockert
-
Quakenbrück, Tyskland, 49610
- Rekrytering
- Neurologisches Studienzentrum Artland
-
Regensburg, Tyskland, 93059
- Rekrytering
- Gemeinschaftspraxis für Neurologie
-
Remscheid, Tyskland, 42853
- Rekrytering
- Gemeinschaftspraxis Dr. Stienker-Fisse & Dr. Fisse
-
Rülzheim, Tyskland, 76761
- Rekrytering
- ZNS Südpfalz
-
Schwetzingen, Tyskland, 68723
- Rekrytering
- Neurologische Praxis Dr. Wagner
-
Siegen, Tyskland, 57076
- Rekrytering
- Praxis für Neurologie und Psychiatrie
-
Siegen, Tyskland, 57072
- Rekrytering
- Gemeinschaftspraxis für Neurologie, Psychiatrie und Psychotherapie
-
Singen, Tyskland, 78224
- Rekrytering
- EMSA - Zentrum für Neurologie?/?Psychiatrie?/?Neuroradiologie
-
Sinsheim, Tyskland, 74889
- Rekrytering
- Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim
-
Steglitz, Tyskland, 12163
- Rekrytering
- Gemeinschaftspraxis Dr. Wolfram von Pannwitz, MBA & Dr. med. Marie Perle Brinckmann
-
Stuttgart, Tyskland, 70174
- Rekrytering
- Praxis Dr. med. Andreas Kowalik, Arzt für Neurologie und Psychiatrie
-
Stuttgart, Tyskland, 70176
- Rekrytering
- Neuropraxis Sotiriadis
-
Stuttgart, Tyskland, 70178
- Rekrytering
- Neurozentrum Stuttgart Mitte Sophienstraße
-
Sundern, Tyskland, 59846
- Rekrytering
- Sauerlandklinik Hachen
-
Tübingen, Tyskland, 72076
- Rekrytering
- Universitätsklinikum Tübingen, Zentrum für Neurologie
-
Ulm, Tyskland, 89078
- Rekrytering
- Nervenfachaerztliche Gemeinschaftspraxis Ulm
-
Unterhaching, Tyskland, 82008
- Rekrytering
- Neuropraxis München Süd
-
Weil der Stadt, Tyskland, 71263
- Rekrytering
- Praxis für Neurologie, Psychiatrie und Epileptologie
-
Wolfratshausen, Tyskland, 82515
- Rekrytering
- Praxis Dr. Michaela Krause
-
Zwickau, Tyskland, 08060
- Rekrytering
- Heinrich-Braun-Krankenhaus Städtisches Klinikum
-
Öhringen, Tyskland, 74613
- Rekrytering
- Dres. Beckmann / Schlüter
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Participants with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS), diagnosed according to McDonald criteria of 2017 or revised McDonald criteria 2024, and treated with ocrelizumab SC for the first time during routine clinical practice will be observed in this study.
Beskrivning
Inclusion Criteria:
- Diagnosis of MS
- RMS and PPMS participants diagnosed according to the McDonald criteria of 2017 or revised McDonald criteria 2024
- First treatment during the course of MS therapy with ocrelizumab SC according to the local prescribing information, regardless of the reason for starting treatment with ocrelizumab
Exclusion Criteria:
- Participation in interventional studies investigating DMTs for MS
- Prior or simultaneous participation in CONFIDENCE or MoOzaRt (ISRCTN55332718) non interventional study (NIS) at the same study site
- Prior treatment with rituximab (MabThera®) or ublituximab (Briumvi®)
- Severe psychiatric disability
- Pregnant women
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Ocrelizumab
Participants who are receiving ocrelizumab, SC injection, for the first time as part of their routine MS therapy at physician's discretion in accordance with local clinical practice and/or labeling will be observed for treatment satisfaction with SC injection for up to 12 months. |
Ocrelizumab will be administered as SC injection as per discretion of the treating physician in accordance with local clinical practice and local labeling.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of Participants by Their Level of Satisfaction With Ocrelizumab SC After 12 Months Assessed Using TASQ-SC
Tidsram: Month 12
|
TASQ-SC is a 12-item, participant-reported questionnaire measuring the impact of treatment administration on five domains: Physical Impact, Psychological Impact, Impact on Activities of Daily Living, Convenience, and Satisfaction. Each of the domain/scale scores is scored on a scale of 1-100, where higher scores indicate higher overall satisfaction with the therapy. |
Month 12
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Koncentration av NfL-proteinnivåer i serum
Tidsram: Baslinje, månad 6, månad 12
|
Baslinje, månad 6, månad 12
|
|
|
Antal deltagare efter deras nivå av tillfredsställelse med Ocrelizumab SC Bedömd av Läkarundersökning
Tidsram: Baslinje, månad 6, månad 12
|
Baslinje, månad 6, månad 12
|
|
|
Årlig återfallsfrekvens
Tidsram: Månad 12
|
Månad 12
|
|
|
Andel deltagare med progression oberoende av återfallsaktivitet (PIRA)
Tidsram: Upp till månad 12
|
Upp till månad 12
|
|
|
Antal deltagare med icke-seriösa biverkningar (NSAE), allvarliga biverkningar (SAE) och biverkningar av särskilt intresse (AESI)
Tidsram: Upp till månad 12
|
Upp till månad 12
|
|
|
Change From Baseline in NfL Protein Levels in Serum
Tidsram: Baseline, Month 6, Month 12
|
Baseline, Month 6, Month 12
|
|
|
Number of Participants by Their Level of Satisfaction With Ocrelizumab SC After the First Injection and After 6 Months Assessed Using TASQ-SC
Tidsram: Baseline, Month 6
|
TASQ-SC is a 12-item, participant-reported questionnaire measuring the impact of treatment administration on five domains: Physical Impact, Psychological Impact, Impact on Activities of Daily Living, Convenience, and Satisfaction. Each of the domain/scale scores is scored on a scale of 1-100, where higher scores indicate higher overall satisfaction with the therapy. |
Baseline, Month 6
|
|
Correlation Between NfL Protein Levels in Serum With MS Relapse
Tidsram: Up to Month 12
|
The changes in levels of NfL protein levels in serum and its correlation with MS relapse will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Expanded Disability Status Scale (EDSS)
Tidsram: Up to Month 12
|
The changes in levels of NfL protein levels in serum and its correlation with EDSS will be analyzed using Pearson or Spearman correlation coefficients. EDSS is a scale for assessing neurologic impairment in MS. Values are from 0 points (normal neurological examination) up to 10 points (death), increasing in increments of 0.5 points. Higher scores represent increased disability. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Previous MS Disease Modifying Therapy (DMT)
Tidsram: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with DMT will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Serum Creatinine
Tidsram: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with serum creatinine will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Co-morbidities
Tidsram: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with co-morbidities will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Age
Tidsram: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with age will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Body Mass Index [BMI]
Tidsram: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with BMI will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Magnetic Resonance Imaging (MRI) Lesion Count
Tidsram: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with MRI lesion count will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Glial Fibrillary Acidic Protein (GFAP) Levels
Tidsram: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with GFAP levels will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With No Evidence of Disease Activity-3 (NEDA-3)
Tidsram: Up to Month 12
|
NEDA-3 is defined by no confirmed MS relapse, no new or enlarging T2 lesions, no Gadolinium-positive T1 lesions, and no six-month confirmed disability worsening. The changes in levels of NfL protein in serum and its correlation with NEDA-3 will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Change From Baseline in Participant Satisfaction With Ocrelizumab SC Assessed Using Treatment Satisfaction Questionnaire for Medication (TSQM) 1.4
Tidsram: Baseline, Month 6, Month 12
|
TSQM version 1.4 is a 14-item questionnaire used to measure level of satisfaction or dissatisfaction with the medication on 4 domains: Effectiveness, Side Effects, Convenience, and Global Satisfaction. Each of the domain is scored on likert-type scales of 5 or 7 points ranging from 1 (least satisfied) to 5 or 7 (most satisfied). Item scores are summarized to give four domain scores, which are in turn transformed to a scale of 0-100. Higher scores indicate higher overall satisfaction with the therapy. |
Baseline, Month 6, Month 12
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Clinical Trials, Hoffmann-La Roche
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ML45551
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
For eligible studies, qualified researchers may request access to individual patient level clinical data. See Roche's commitment to transparency of clinical study information here: https://go.roche.com/data_sharing
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .